SVB Leerink Initiates Coverage On Bristol-Myers Squibb with Market Perform Rating, Announces Price Target of $66
Portfolio Pulse from richadhand@benzinga.com
SVB Leerink analyst David Risinger has initiated coverage on Bristol-Myers Squibb (NYSE:BMY) with a Market Perform rating and a price target of $66.
July 10, 2023 | 1:48 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bristol-Myers Squibb has been initiated with a Market Perform rating by SVB Leerink with a price target of $66.
The initiation of coverage by SVB Leerink with a Market Perform rating suggests that the analyst believes Bristol-Myers Squibb's stock will perform in line with the market. The price target of $66 indicates the analyst's expectation of the stock's future price. This news could influence investors' perception of the stock, but it's not clear whether it will lead to a significant price movement in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100